LAUREN ALVARADO: Open Payments
NPI 1992301642 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 40 payments from 11 companies in 2025. Trend: 2023 $700 · 2024 $1,111 · 2025 $703
Food & beverage: $658Education: $45
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $174 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $104 |
| Lilly USA, LLC | 3 | $81 |
| ABBVIE INC. | 4 | $80 |
| Novo Nordisk Inc | 3 | $71 |
| Dexcom, Inc. | 3 | $51 |
| Astellas Pharma US Inc | 2 | $43 |
| Inspire Medical Systems, Inc. | 1 | $39 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
Products named: TRELEGY ELLIPTA, JARDIANCE, SHINGRIX, VRAYLAR, Dexcom G6 Transmitter, Veozah, INSPIRE, MOUNJARO.
Industry payments across TX — which companies pay providers there.
